NBP258625PE

Novus Biologicals™ MGAT2 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP258625PE-Each-of-1 In Stock ₹ 31,372.50

NBP258625PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

4247

Common Name

MGAT2 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, Beta-1,2-N-acetylglucosaminyltransferase II, CDG2A, EC 2.4.1.143, GlcNAc-T II, GLCNACTII, GNT2, GNT-IICDGS2, Mannoside acetylglucosaminyltransferase 2, mannosyl (alpha-1,6-)-glycoprot

Label Type

Unlabeled

Quantity

100μL

Research Category

metabolism, Proteases & Other Enzymes

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-52126. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

MGAT2

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Source

E.coli

Related Products

Img

Novus Biologicals™

NBP258283PE

--

Img

Novus Biologicals™

NBP258678PE

--

Img

Novus Biologicals™

NBP259016PE

--

Img

Novus Biologicals™

NBP258642PE

--

Img

Novus Biologicals™

NBP258313PE

--

Img

Novus Biologicals™

NBP258424PE

--

Img

Novus Biologicals™

NBP258554PE

--

Img

Novus Biologicals™

NBP258353PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human MGAT2
  • Source: E.coli Amino Acid Sequence: QVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWER The MGAT2 Recombinant Protein Antigen is derived from E
  • coli
  • The MGAT2 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.